NCT03908671View on ClinicalTrials.gov

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 18, 2019

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2025

Conditions
Esophageal CancerNon Small Cell Lung Cancer
Interventions
BIOLOGICAL

Personalized mRNA Tumor Vaccine

subcutaneous injection with personalized mRNA tumor vaccine

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

lead

Stemirna Therapeutics

INDUSTRY

NCT03908671 - Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Esophageal Cancer and Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter